Pancreatic Cancer Research

ResearcherThe University of Texas MD Anderson Cancer CenterNo recent work listed

Liuqing Yang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-6518-474X; OpenAlex author ID A5052747073. Sources: OpenAlex.

Their work

Papers
3 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
16
Papers, trials and grants by year

2021: 2 papers · 2022: none · 2023: 1 paper

Papers 3

  1. Tumor-associated nonmyelinating Schwann cell-expressed PVT1 promotes pancreatic cancer kynurenine pathway and tumor immune exclusion. Last author DOI 10.1126/sciadv.add6995↗
  2. A novel class of tsRNA signatures as biomarkers for diagnosis and prognosis of pancreatic cancer. First author DOI 10.1186/s12943-021-01389-5↗
  3. Nuclear translocation of the receptor tyrosine kinase c-MET reduces the treatment efficacies of olaparib and gemcitabine in pancreatic ductal adenocarcinoma ce… Co-author PMID 33520371↗

Closest collaborators

The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Dihua Yu · 2 shared papers, 2021–2023 · strength 0.27
  2. Mien‐Chie Hung · 2 shared papers, 2021–2023 · strength 0.27
  3. Yingbin Liu · 1 shared paper, 2021 · strength 0.15
  4. Yuan Gao · 1 shared paper, 2021 · strength 0.15
  5. Yanbo Wang · 1 shared paper, 2021 · strength 0.13
  6. Fangfang Jin · 1 shared paper, 2021 · strength 0.13
  7. David R Piwnica-Worms · 1 shared paper, 2023 · strength 0.12
  8. Jianjun Gao · 1 shared paper, 2023 · strength 0.12
  9. Wei Hu · 1 shared paper, 2023 · strength 0.12
  10. Youqiong Ye · 1 shared paper, 2023 · strength 0.12
  11. Cheng‐Cao Sun · 1 shared paper, 2023 · strength 0.12
  12. Jun Yao · 1 shared paper, 2023 · strength 0.12
  13. Haoqiang Ying · 1 shared paper, 2023 · strength 0.12
  14. Paul J. Chiao · 1 shared paper, 2023 · strength 0.12
  15. George A. Călin · 1 shared paper, 2023 · strength 0.12
  16. Michael A. Curran · 1 shared paper, 2023 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.